Grayson Rodriguez, PhD Profile
Grayson Rodriguez, PhD

@grayerodriguez

Followers
200
Following
539
Media
4
Statuses
118

Proteins & signaling in the Garcia Lab | @StanfordCVI T32 Fellow | @stanfordimmuno PhD | Formerly @parkerICI, @ChemistryMIT, & @kochinstitute

Joined April 2022
Don't wanna be here? Send us removal request.
@grayerodriguez
Grayson Rodriguez, PhD
11 days
Super neat use of nanobody generation!
@Nature
nature
12 days
Nature research paper: Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites https://t.co/MIaU0hD3W0
0
0
0
@washingtonpost
The Washington Post
1 month
Breaking news: MIT’s president turned down the Trump administration’s offer of priority access for federal funding, publicly releasing a letter that emphasized the elite university’s values.
Tweet card summary image
washingtonpost.com
MIT is one of nine schools that were asked to agree to adopt conservative priorities and policies in exchange for funding perks.
47
145
411
@parkerici
Parker Institute for Cancer Immunotherapy
1 month
Congrats to Mary Brunkow, Shimon Sakaguchi & PICI scientific advisor & former CSO Fred Ramsdell, for receiving the @NobelPrize for their work on peripheral immune tolerance. This recognition reinforces why deep study of the immune system remains central to scientific progress.
@NobelPrize
The Nobel Prize
1 month
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
0
3
19
@NobelPrize
The Nobel Prize
1 month
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
468
12K
29K
@LabWaggoner
Waggoner Lab
1 month
Review @NatRevImmunol Regulators of CD8+ T cell exhaustion https://t.co/JF3pDpd9Ym
0
3
13
@GitaAbhiraman
Gita Abhiraman, MD, PhD
1 month
Excited to share this work from my PhD! See our structure below of a computationally designed IL-21 mimic with anti-tumor efficacy in mice. A collaboration between the David Baker, Stephanie & Mike Dougan, Warren Leonard, and Chris Garcia labs.
@SciImmunology
Science Immunology
1 month
Scientists have designed an interleukin-21 mimic with increased stability and capacity to induce more potent #antitumor activity than the native protein, which could inform improved #immunotherapies. @UWproteindesign Learn more in Science #Immunology: https://t.co/WR1foQx6Mq
11
37
321
@SciImmunology
Science Immunology
1 month
Scientists have designed an interleukin-21 mimic with increased stability and capacity to induce more potent #antitumor activity than the native protein, which could inform improved #immunotherapies. @UWproteindesign Learn more in Science #Immunology: https://t.co/WR1foQx6Mq
1
34
110
@Nature
nature
2 months
The US president repeatedly advised people, “Don't take Tylenol,” but scientists say that strong evidence between the medication and autism is lacking https://t.co/yNhKXkSFrB
Tweet card summary image
nature.com
Nature - During an announcement on Monday, the US president repeatedly advised people, ‘Don’t take Tylenol’, but scientists say that strong evidence between the medication and autism is lacking.
4
16
48
@grayerodriguez
Grayson Rodriguez, PhD
2 months
Grateful to share that my postdoc training continues with the support of the Mechanisms & Innovations in CVD T32 Grant from @StanfordCVI! Just attended the Immuno-Cardiology Symposium at @jacksonlab & @MDIBL in Bar Harbor and am excited to apply protein engineering to the field.
0
0
3
@RetickerFlynn
Nathan Reticker-Flynn
2 months
Tumors often metastasize to lymph nodes before distant sites, yet evidence suggests that distant mets can originate from unique clones. Is this divergent seeding random? No. Check out our newest @biorxivpreprint to learn how the mechanisms diverge and how to harness them for IO.
@CortBreuer
Cort Breuer
2 months
I’m excited to share the first major story from my PhD today on the complex role of type 1 interferon in metastasis and immunotherapy! This work was made possible with the support of @RetickerFlynn, Marcos Labrado, and the incredible protein engineer @grayerodriguez
2
5
17
@grayerodriguez
Grayson Rodriguez, PhD
2 months
Check out this preprint from @CortBreuer and @RetickerFlynn - always grateful for the opportunity to collaborate with them as they uncover the methods and molecular basis of metastasis!
@biorxiv_cancer
bioRxiv Cancer Bio
2 months
Type I interferon signaling instills divergent metastatic phenotypes and immunotherapy responses https://t.co/cWARY9DL3P #biorxiv_cancer
0
1
3
@CortBreuer
Cort Breuer
2 months
I’m excited to share the first major story from my PhD today on the complex role of type 1 interferon in metastasis and immunotherapy! This work was made possible with the support of @RetickerFlynn, Marcos Labrado, and the incredible protein engineer @grayerodriguez
@biorxiv_cancer
bioRxiv Cancer Bio
2 months
Type I interferon signaling instills divergent metastatic phenotypes and immunotherapy responses https://t.co/cWARY9DL3P #biorxiv_cancer
1
3
26
@MasatoOgishi
Masato OGISHI
3 months
Amazing plasticity in T cells revealed through synthetic biology. Bold science spearheaded by my friend @YangZhao102 and co-led by @xrtcell and Chris Garcia. Huge congrats to Yang and the team!
@YangZhao102
Yang Zhao
3 months
Excited to share our @Nature papers exploiting the receptor pairing code to expand the cytokine receptor alphabet in T cells. Nonnatual receptors reprograms T cells into myeloid lineage. Grateful for the amazing collaborators @xrtcell , @MasatoOgishi
0
2
17
@YangZhao102
Yang Zhao
3 months
Excited to share our @Nature papers exploiting the receptor pairing code to expand the cytokine receptor alphabet in T cells. Nonnatual receptors reprograms T cells into myeloid lineage. Grateful for the amazing collaborators @xrtcell , @MasatoOgishi
8
20
135
@xrtcell
Anusha Kalbasi
3 months
Pleasure to share a tremendous body of work from @YangZhao102, who led the next chapter of the powerful orthogonal IL-2 technology from the Garcia Lab (where the innovative spirit is unmatched). Grateful for this ongoing collaboration, stay tuned for more.
1
7
35
@KlebanoffLab
Klebanoff_Lab
3 months
🚨More cytokine-signaling magic from the @xrtcell and Garcia labs. Non-natural signal pairing with the common gamma chain receptor can drive unique transcriptional programs in T cells. 🤯This includes induction of phagocytic T cells by pairing with GSCFR!!
0
11
58
@LabWaggoner
Waggoner Lab
3 months
Expanding the cytokine receptor alphabet reprograms T cells into diverse states @Nature #GarciaLab @xrtcell https://t.co/z8b3ckEIm7
0
28
135
@grayerodriguez
Grayson Rodriguez, PhD
3 months
An incredible follow up to the Garcia Lab ortho-IL-2 receptor system published in @Nature today led by @YangZhao102. It's been an honor learning from Yang and co-authors in the process of bringing this project to fruition. A tour de force- check it out!
0
3
10
@grayerodriguez
Grayson Rodriguez, PhD
3 months
Congratulations to @CortBreuer on his first author article in @NatureProtocols out today! It was neat learning more about the model while working together. The @RetickerFlynn Lab is the place to go for these metastatic models.
0
1
8
@CortBreuer
Cort Breuer
3 months
Excited to see our protocol out today on spontaneous and experimental models of LN metastasis in @NatureProtocols! Though a straightforward system conceptually, getting these models working reliably took more time than originally expected so I hope this is a resource to everyone.
2
2
5